A Randomised, Placebo-controlled Single-blind, Single-centre Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2010
At a glance
- Drugs AZD 4818 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 22 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jun 2008 New trial record.